CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS
Dead / Abandoned — Abandoned — failure to respond (as of 01 Oct 2022)
What this means for you
This application is over — abandoned 20 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97079346
- Mark type
- Design + words
- Filed
- 18 Oct 2021
- Abandoned
- 20 Sept 2022
- Attorney of record
- Joshua M. Gerben, Esq.
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
- Class 044 — Medical, beauty and agricultural services: Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
Owner
- CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC, KING OF PRUSSIA, PA, US
- MORNING LIGHT IP, LLC, Radnor, PA, US
Prosecution history
- 03 Oct 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Oct 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 18 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2022 — NON-FINAL ACTION E-MAILED
- 18 Mar 2022 — NON-FINAL ACTION WRITTEN
- 04 Mar 2022 — ASSIGNED TO EXAMINER
- 26 Jan 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Nov 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 04 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Oct 2021 — NEW APPLICATION ENTERED